Inhibition of Advanced Prostate Cancer by Androgens and Liver X Receptor Agonists

QR Code

Inhibition of Advanced Prostate Cancer by Androgens and Liver X Receptor Agonists

None

Saved in:

Bibliographic Details
Main Authors:	Chuu, Chih-Pin, Lin, Hui-Ping, Lin, Ching-Yu, Huo, Chiech, Su, Liang-Cheng
Format:	Electronic Book Chapter
Language:	English
Published:	IntechOpen 2011
Subjects:	Health Sciences
Online Access:	https://www.intechopen.com/chapters/24270
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Intermittent androgen therapy in prostate cancer reveals the pro-apoptotic roles of androgen/androgen receptor: an overview
by: Saleh Altuwaijri, et al.
Published: (2025-03-01)

Dissecting the roles of the androgen receptor in prostate cancer from molecular perspectives
by: Jieping Hu, et al.
Published: (2017-04-01)

Androgen Receptor Signalling in Prostate Cancer: Mechanisms of Resistance to Endocrine Therapies
by: Quistini A, et al.
Published: (2025-06-01)

Androgen Deprivation Therapy for Prostate Cancer
by: Ziaran, Stanislav
Published: (2011)

New Approaches Targeting Androgen Receptor Signal Pathways for Treatment of Castration-Resistant Prostate Cancer
by: Donkena, et al.
Published: (2011)

Androgen Deprivation Therapy–Induced Muscle Loss and Fat Gain Predict Cardiovascular Events in Prostate Cancer Patients
by: Jie Lee, et al.
Published: (2025-06-01)

Bitter taste receptor agonists induce vasorelaxation in porcine coronary arteries
by: Ching-Chung Tsai, et al.
Published: (2025-07-01)

Stem Like Cells and Androgen Deprivation in Prostate Cancer
by: Tang, Yao, et al.
Published: (2011)

Influence of obesity and androgen deficiency on prostatic blood circulation
by: I. A. Tyuzikov, et al.
Published: (2012-04-01)

Identification of Androgen Receptor as a Molecular Docking Target for Survival and Response to Metformin‐Induced Ferroptosis in Liver Cancer
by: Bin Zhang, et al.
Published: (2025-07-01)

Structural Retinal and Optic Nerve Changes in Prostate Cancer Patients Receiving Androgen Receptor Pathway Inhibitors: An OCT-Based In Vivo Analysis
by: Yasemin Bakkal Temi, et al.
Published: (2025-07-01)

The GABAА receptors agonists and antagonists influence on formation of a latent inhibition at rats with different levels of anxiety
by: A. V. Redkina, et al.
Published: (2012-02-01)

Place of imidazoline receptor agonists in the treatment of hypertension
by: D. V. Nebieridze, et al.
Published: (2022-01-01)

Imidazoline receptor agonists and left ventricular hypertrophy
by: L. L. Kirichenko, et al.
Published: (2005-04-01)

Prostate-Specific Antigen Reduction After Androgen Receptor Pathway Inhibitor Initiation: Real-World Comparison of Disease Progression Among Patients With Metastatic Castration-Sensitive Prostate Cancer
by: Shawn Du, et al.
Published: (2025-07-01)

Skeletal Scintigraphy in Assesing the Response of Prostate Cancer Metastases to Androgen Deprivation Therapy
by: S. P. Mironov, et al.
Published: (2021-09-01)

CAG Expansion in Androgen Receptor Gene of Infertile Men in Erbil Governorate
by: Dashne Abdulla Salih, et al.
Published: (2023-01-01)

Correction of Thrombocytopenia with Thrombopoietin Receptor Agonists in Patients with Liver Cirrhosis Before Elective Surgery or Invasive Procedures
by: T. A. Deeva, et al.
Published: (2025-02-01)

A SARM a Day Keeps the Weakness Away: A Computational Approach for Selective Androgen Receptor Modulators (SARMs) and Their Interactions with Androgen Receptor and 5‑Alpha Reductase Proteins
by: Mustafa Munir Mustafa Dahleh, et al.
Published: (2025-07-01)

Place of imidazoline receptor agonists in the treatment of arterial hypertension
by: D. V. Nebieridze, et al.
Published: (2023-12-01)

FUNCTIONAL AND MORPHOMETRIC EVALUATION OF PROSTATE MICROCIRCULATION FOLLOWING HIGH-INTENSITY FOCUSED ULTRASOUND THERAPY WITH ANDROGEN DEPRIVATION FOR PROSTATIC ADENOCARCINOMA
by: V. P. Levin, et al.
Published: (2019-02-01)

Effect of a Farnesoid X-receptor Agonist on Postprandial Lipemia in Rats Fed a Supraphysiological Fat Dozes
by: Yu. N. Alekhin, et al.
Published: (2023-05-01)

Prostate Cancer Progression to Androgen Independent Disease: The Role of the Wnt/β-Catenin Pathway
by: Ha, Jacqueline R., et al.
Published: (2011)

Androgen receptor expression in triple negative breast cancer: an Algerian population study
by: Amel Hedjem, et al.
Published: (2025-12-01)

Intermittent Androgen Suppression Therapy for Prostate Cancer Patients: A Choice for Improved Quality of Life?
by: Hamilton, Gerhard, et al.
Published: (2011)

The urgency of the androgenic screening for men who underwent preventive medical examination for prostate diseases detection
by: A. A. Kamalov, et al.
Published: (2012-12-01)

Functional interaction of fibroblast growth factor 8b and androgen in prostate cancer cell proliferation
by: Wen-jun Xiao, et al.
Published: (2017-04-01)

Imidazoline receptor agonists: more than blood pressure reduction?
by: D. V. Nebieridze, et al.
Published: (2006-04-01)

Thrombopoietin Receptor Agonists: Clinical Use and Evaluation of Treatment Efficacy
by: A. G. Solodovnikov, et al.
Published: (2020-12-01)

Complications of thrombopoietin receptor agonists therapy in patients with immune thrombocytopenia
by: S. G. Zakharov, et al.
Published: (2024-04-01)

Theory and practice of selective imidazoline receptor agonist use in Russia
by: N. I. Gaponova, et al.
Published: (2024-07-01)

PLEIOTROPIC EFFECTS OF PARATHYROIDECTOMY AND AGONIST CALCIUM-SENSITIVE RECEPTOR, CINACALCET
by: L. V. Egshatyan, et al.
Published: (2015-09-01)

Glucagon-like Peptide-1 Receptor Agonists (GLP-1 RAs): A Pan-Steatotic Liver Disease Treatment?
by: Lampros Chrysavgis, et al.
Published: (2025-06-01)

ANDROGEN RECEPTORS AS A FACTOR OF PROGNOSIS IN VARIOUS MOLECULAR-BIOLOGICAL SUBTYPES OF BREAST CANCER
by: D. A. Ryabchikov, et al.
Published: (2017-07-01)

Role of Nuclear Receptors Peroxisome Proliferator-Activated Receptors (PPARs) and Liver X Receptors (LXRs) in the Human Placental Pathophysiology
by: Marceau, Geoffroy, et al.
Published: (2012)

Cardiovascular Effects of Androgens
by: Wilson, Carlos, et al.
Published: (2011)

Androgens and Vascular Function
by: Ferrer, Mercedes
Published: (2011)

Association between the molecular markers, effect and time of response to the androgen-deprivation therapy in patients with prostate cancer
by: L. V. Spirina, et al.
Published: (2019-04-01)

Place of agonists Imidazol(in)e Receptors in arterial hypertension patients therapy
by: A. N. Britov, et al.
Published: (2006-02-01)

Opioid Kappa Receptor Selective Agonist TRK-820 (Nalfurafine Hydrochloride)
by: Fujii, Hideaki, et al.
Published: (2012)